1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	NF-kappa	NF-kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	T-cell	t-cell	_	_	_	_	_	_	_
9	lines	line	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	anetholdithiolthione	anetholdithiolthione	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Nuclear	nuclear	_	_	_	_	_	_	_
2	factor	factor	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	NF)-kappa	NF)-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	redox	redox	_	_	_	_	_	_	_
9	sensitive	sensitive	_	_	_	_	_	_	_
10	cytosolic	cytosolic	_	_	_	_	_	_	_
11	transcription	transcription	_	_	_	_	_	_	_
12	factor	factor	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Redox	Redox	_	_	_	_	_	_	_
2	regulation	regulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	has	have	_	_	_	_	_	_	_
7	been	be	_	_	_	_	_	_	_
8	implicated	implicate	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	activation	activation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	human	human	_	_	_	_	_	_	_
15	immuno-deficiency	immuno-deficiency	_	_	_	_	_	_	_
16	virus	virus	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	HIV	HIV	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Therefore	therefore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	inhibition	inhibition	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NF-kappa	NF-kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	may	may	_	_	_	_	_	_	_
9	be	be	_	_	_	_	_	_	_
10	an	an	_	_	_	_	_	_	_
11	effective	effective	_	_	_	_	_	_	_
12	strategy	strategy	_	_	_	_	_	_	_
13	for	for	_	_	_	_	_	_	_
14	acquired	acquire	_	_	_	_	_	_	_
15	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
16	syndrome	syndrome	_	_	_	_	_	_	_
17	therapy	therapy	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Anetholdithiolthione	Anetholdithiolthione	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	ADT	ADT	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione	5-[p-methoxyphenyl]-3h-1,2-dithiol-3-thione	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	an	an	_	_	_	_	_	_	_
9	antioxidant	antioxidant	_	_	_	_	_	_	_
10	which	which	_	_	_	_	_	_	_
11	has	have	_	_	_	_	_	_	_
12	been	be	_	_	_	_	_	_	_
13	used	use	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	protect	protect	_	_	_	_	_	_	_
16	against	against	_	_	_	_	_	_	_
17	acetaminophen-	acetaminophen-	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	CCl4-induced	ccl4-induced	_	_	_	_	_	_	_
20	hepatotoxicity	hepatotoxicity	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	lipid	lipid	_	_	_	_	_	_	_
23	peroxidation	peroxidation	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	radiation	radiation	_	_	_	_	_	_	_
26	injury	injury	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	also	also	_	_	_	_	_	_	_
30	has	have	_	_	_	_	_	_	_
31	been	be	_	_	_	_	_	_	_
32	used	use	_	_	_	_	_	_	_
33	clinically	clinically	_	_	_	_	_	_	_
34	as	as	_	_	_	_	_	_	_
35	an	an	_	_	_	_	_	_	_
36	anti-choleretic	anti-choleretic	_	_	_	_	_	_	_
37	agent	agent	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	present	present	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	examined	examine	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	effect	effect	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	ADT	ADT	_	_	_	_	_	_	_
9	pretreatment	pretreatment	_	_	_	_	_	_	_
10	on	on	_	_	_	_	_	_	_
11	NF-kappa	NF-kappa	_	_	_	_	_	_	_
12	B	B	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	response	response	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	variety	variety	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	stimuli	stimulus	_	_	_	_	_	_	_
21	such	such	_	_	_	_	_	_	_
22	as	as	_	_	_	_	_	_	_
23	H2O2	h2o2	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	phorbol	phorbol	_	_	_	_	_	_	_
26	myristate	myristate	_	_	_	_	_	_	_
27	acetate	acetate	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	PMA	PMA	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	or	or	_	_	_	_	_	_	_
32	tumor	tumor	_	_	_	_	_	_	_
33	necrosis	necrosis	_	_	_	_	_	_	_
34	factor	factor	_	_	_	_	_	_	_
35	alpha	alpha	_	_	_	_	_	_	_
36	(	(	_	_	_	_	_	_	_
37	TNF	TNF	_	_	_	_	_	_	_
38	alpha	alpha	_	_	_	_	_	_	_
39	)	)	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	PMA	PMA	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	TNF	TNF	_	_	_	_	_	_	_
4	alpha	alpha	_	_	_	_	_	_	_
5	induced	induce	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	NF)-kappa	NF)-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	human	human	_	_	_	_	_	_	_
13	Jurkat	Jurkat	_	_	_	_	_	_	_
14	T-cells	T-cell	_	_	_	_	_	_	_
15	was	be	_	_	_	_	_	_	_
16	partially	partially	_	_	_	_	_	_	_
17	inhibited	inhibit	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	ADT	ADT	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	0.1	0.1	_	_	_	_	_	_	_
22	mM	mM	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	pretreatment.	pretreatment.	_	_	_	_	_	_	_
25	ADT	ADT	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	0.1	0.1	_	_	_	_	_	_	_
28	mM	mM	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	also	also	_	_	_	_	_	_	_
31	inhibited	inhibit	_	_	_	_	_	_	_
32	H2O2	h2o2	_	_	_	_	_	_	_
33	induced	induced	_	_	_	_	_	_	_
34	activation	activation	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	transcription	transcription	_	_	_	_	_	_	_
38	factor	factor	_	_	_	_	_	_	_
39	in	in	_	_	_	_	_	_	_
40	the	the	_	_	_	_	_	_	_
41	peroxide	peroxide	_	_	_	_	_	_	_
42	sensitive	sensitive	_	_	_	_	_	_	_
43	human	human	_	_	_	_	_	_	_
44	Wurzburg	Wurzburg	_	_	_	_	_	_	_
45	T-cells	T-cell	_	_	_	_	_	_	_
46	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	ADT	ADT	_	_	_	_	_	_	_
4	treated	treat	_	_	_	_	_	_	_
5	Wurzburg	Wurzburg	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	had	have	_	_	_	_	_	_	_
8	significantly	significantly	_	_	_	_	_	_	_
9	higher	high	_	_	_	_	_	_	_
10	glutathione	glutathione	_	_	_	_	_	_	_
11	levels	level	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	compared	compare	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	untreated	untreated	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	H2O2	H2O2	_	_	_	_	_	_	_
2	induced	induce	_	_	_	_	_	_	_
3	lipid	lipid	_	_	_	_	_	_	_
4	peroxidation	peroxidation	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	Wurzburg	Wurzburg	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	remarkably	remarkably	_	_	_	_	_	_	_
10	inhibited	inhibit	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	ADT	ADT	_	_	_	_	_	_	_
13	pretreatment	pretreatment	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	ADT	ADT	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	pro-glutathione	pro-glutathione	_	_	_	_	_	_	_
5	antioxidant	antioxidant	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	observed	observe	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	be	be	_	_	_	_	_	_	_
11	capable	capable	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	modulating	modulate	_	_	_	_	_	_	_
14	NF-kappa	NF-kappa	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	activation	activation	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

